Literature DB >> 15348607

Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate.

Maria Grazia Cascone1, Luigi Lazzeri, Claudia Carmignani, Zhouhai Zhu.   

Abstract

Biodegradable hydrophilic gelatin nanoparticles, containing different initial amounts of methotrexate (MTX), were prepared using a simple solvent evaporation technique based on a single water-in-oil emulsion and stabilized by the use of glutaraldehyde as cross-linking agent. The effects of several parameters on particle size, drug encapsulation efficiency and drug release were investigated. Size and shape of the nanoparticles were examined by scanning electron microscopy. The release of MTX was monitored in vitro and the mechanism of release was studied. Particles with a mean diameter of 100-200 nm were produced, which were able to release MTX following a diffusion-controlled mechanism of release. It was observed that the initial amount of MTX used for sample loading did not have any effect on the pattern of release, while it affected the amount of drug entrapped into the nanoparticles and also both the release rate and the total amount of drug released.

Entities:  

Year:  2002        PMID: 15348607     DOI: 10.1023/a:1014791327253

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  10 in total

1.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

2.  Biodegradable microparticles as controlled release antigen delivery systems.

Authors:  D T O'Hagan; D Rahman; J P McGee; H Jeffery; M C Davies; P Williams; S S Davis; S J Challacombe
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

3.  A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles.

Authors:  T Harmia; P Speiser; J Kreuter
Journal:  J Microencapsul       Date:  1986 Jan-Mar       Impact factor: 3.142

4.  Nanoparticles--a new colloidal drug delivery system.

Authors:  J J Marty; R C Oppenheim; P Speiser
Journal:  Pharm Acta Helv       Date:  1978

5.  PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

Authors:  T Govender; S Stolnik; M C Garnett; L Illum; S S Davis
Journal:  J Control Release       Date:  1999-02-01       Impact factor: 9.776

Review 6.  Nanoparticles in drug delivery.

Authors:  S J Douglas; S S Davis; L Illum
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

7.  Lactic acid oligomer microspheres containing hydrophilic drugs.

Authors:  R Wada; S H Hyon; Y Ikada
Journal:  J Pharm Sci       Date:  1990-10       Impact factor: 3.534

8.  Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement.

Authors:  J Molpeceres; M Guzman; M R Aberturas; M Chacon; L Berges
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

9.  Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.

Authors:  R Narayani; K P Rao
Journal:  J Microencapsul       Date:  1994 Jan-Feb       Impact factor: 3.142

10.  In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure.

Authors:  E Allémann; J C Leroux; R Gurny; E Doelker
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

  10 in total
  16 in total

1.  Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate.

Authors:  A K Bajpai; Jyoti Choubey
Journal:  J Mater Sci Mater Med       Date:  2006-04       Impact factor: 3.896

2.  Producing gelatin nanoparticles as delivery system for bovine serum albumin.

Authors:  Bahareh Azimi; Parviz Nourpanah; Mohammad Rabiee; Shahram Arbab
Journal:  Iran Biomed J       Date:  2014

Review 3.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

4.  Influence of formulation factors on the preparation of zein nanoparticles.

Authors:  Satheesh Podaralla; Omathanu Perumal
Journal:  AAPS PharmSciTech       Date:  2012-06-26       Impact factor: 3.246

5.  Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system.

Authors:  Nader Taheri Qazvini; Sahar Zinatloo
Journal:  J Mater Sci Mater Med       Date:  2010-11-04       Impact factor: 3.896

6.  Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.

Authors:  Mahesh D Chavanpatil; Ayman Khdair; Jayanth Panyam
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

7.  Evaluation of anticancer effects of carboplatin-gelatin nanoparticles in different sizes synthesized with newly self-assembly method by exposure to IR light.

Authors:  Ferdane Danışman-Kalındemirtaş; İshak Afşin Kariper; Gökçe Erdemir; Esra Sert; Serap Erdem-Kuruca
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

8.  A Freezing and Thawing Method for Fabrication of Small Gelatin Nanoparticles with Stable Size Distributions for Biomedical Applications.

Authors:  Yonghyun Gwon; Woochan Kim; Sunho Park; Sewoon Hong; Jangho Kim
Journal:  Tissue Eng Regen Med       Date:  2021-09-26       Impact factor: 4.451

9.  Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats.

Authors:  Jing Zhang; Xizhen Han; Xiang Li; Yun Luo; Haiping Zhao; Ming Yang; Bin Ni; Zhenggen Liao
Journal:  Int J Nanomedicine       Date:  2012-08-06

Review 10.  Drug delivery and nanoparticles:applications and hazards.

Authors:  Wim H De Jong; Paul J A Borm
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.